missing translation for 'onlineSavingsMsg'
Learn More

Pilaralisib analogue, MedChemExpress

Product Code. 16415296
Encompass_Preferred
Click to view available options
Quantity:
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
This item is not returnable. View return policy

Product Code. 16415296

Brand: Medchem Express HY11105

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.

Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.

Specifications

Chemical Name or Material Pilaralisib analogue
CAS 956958-53-5
Color Brown
Purity Grade Notes Research
Molecular Formula C21H16N6O2S2
Quantity 100 mg
Synonym XL147 analogue
Solubility Information DMSO : ≥ 50 mg/mL (111.48 mM)
SMILES O=S(C1=CC=C(C)C=C1)(NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4)=O
Molecular Weight (g/mol) 448.52
Formula Weight 448.52
Percent Purity 99.67%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.